The global sugar-based excipients market size was valued at USD 1.41 billion in 2025 and is projected to grow from USD 1.48 billion in 2026 to USD 2.19 billion by 2034 at a CAGR of 5.04% during the forecast period 2026-2034. Europe dominated the sugar-based excipients market with a market share of 34% in 2025.
Sugar-based excipients are inactive ingredients used in drugs to support the active ingredient, bulk the solid formulation, and maintain stability. Gum, syrups, starch, and others are excipients. This reduces viscosity and improves solubility. Excipients give medicine taste, color, and texture. Pure sugar, polymers, complex starches, and even human and gelatin are excipients. Sugar-based excipients are pharmaceutical fillers, tonicity modifiers, diluents, and sweeteners. Mannitol, an expensive sugar-based excipient, refreshes chewable tablets like lozenges.
The sugar alcohol industry is benefiting from Mannitol's wide range of dosages. Granular, powder, crystal, and syrup sugar-based excipients market are available. Sugar-based excipients may contain harmful impurities. Impurities can cause dangerous immune responses in patients. Oral prescription drugs use sugar-based excipients most often. It is mainly considered for test-biter medications coordinated with the active ingredient.
Download a Free Sample To learn more about this report,
The sugar-based excipients market is being shaped by rising demand for reliable pharmaceutical formulations, especially oral solid dosage medicines. Global diabetes cases reached 830 million in 2022, increasing the need for long-term drug treatment and supporting demand for excipients used in tablets and capsules. At the same time, the growing burden of obesity is increasing demand for chronic-disease medicines and newer therapies. Manufacturing quality is also becoming a stronger focus.
In April 2025, WHO issued updated good manufacturing practice guidance for pharmaceutical excipients, covering their production, control, storage, and distribution. This is likely to encourage pharmaceutical companies to strengthen supplier qualification and quality controls. In addition, supply-chain resilience is becoming important as regulators address medicine shortages and dependence on overseas pharmaceutical manufacturing.
A major driver for sugar-based excipients is the expanding global demand for medicines to manage chronic diseases. WHO reported that the number of people living with diabetes increased from 200 million in 1990 to 830 million in 2022, creating sustained demand for pharmaceutical products. Sugar-based excipients can support drug formulations as diluents, fillers, sweeteners, and other functional ingredients, particularly in oral medicines. The growth of obesity-related healthcare needs is another supporting factor, with WHO reporting that 1 in 8 people worldwide were living with obesity in 2022. Pharmaceutical manufacturers are also investing in more resilient supply chains, creating opportunities for qualified excipient suppliers that can provide consistent quality and reliable availability.
The market faces several challenges, including strict quality requirements, raw-material supply risks, and concerns about the suitability of certain sugar-based ingredients for specific patient groups. WHO's 2025 GMP guidance for pharmaceutical excipients highlights the need for strong controls over production, quality, storage, and distribution, which can increase compliance requirements for manufacturers. Sugar-based ingredients may also face limitations in formulations intended for patients who need to manage blood glucose levels, encouraging developers to consider alternative excipients or artificial sweeteners. Supply-chain disruptions are another concern. The FDA identifies manufacturing problems, raw-material delays, and sudden demand increases among factors that can contribute to medicine shortages, highlighting the importance of dependable excipient supply networks.
The sugar-based excipients market has opportunities in the growing production of oral medicines, especially generic and essential drugs. WHO's 2024 guidance on pharmaceutical excipients highlights the importance of consistent quality and risk-based manufacturing, creating opportunities for suppliers that can offer strong quality systems and traceability. The expansion of pharmaceutical manufacturing in emerging markets also creates room for local and regional excipient supply networks. Another opportunity is the development of specialized sugar-based excipients with better flow, compressibility, and stability for modern tablet formulations. Suppliers that combine pharmaceutical-grade quality with reliable sourcing and technical support can benefit as drug manufacturers seek to reduce supply risks and improve production efficiency.
The market faces challenges from strict quality requirements, supply-chain risks, and the need to prevent contamination or substitution of pharmaceutical-grade materials. In 2025, WHO highlighted serious vulnerabilities in the global excipient supply chain after documenting at least 25 contamination incidents over 90 years that caused more than 1,300 deaths. Regulatory compliance is another challenge because manufacturers must maintain consistent quality, purity, storage, and distribution controls. Drug shortages can also affect excipient availability. The FDA lists raw-material delays, manufacturing problems, shipping disruptions, and shortages of inactive ingredients among recognized causes of medicine supply interruptions
Request Customizationto receive a tailored report.
Actual Sugar is the leading segment in the Sugar-Based Excipients Market, accounting for a 45% market share and recording a 5.5% CAGR. Actual sugar is widely used in pharmaceutical formulations because of its functional properties and suitability for different dosage forms. It can serve as a practical excipient in formulations where manufacturers need consistent performance and reliable processing characteristics. The segment benefits from continued demand for pharmaceutical products, particularly oral medicines that require suitable ingredients to improve formulation quality and manufacturing efficiency.
Powders lead the Sugar Based Excipients Market by type, holding a 35% market share and registering a 6.8% CAGR. Powdered excipients are important in pharmaceutical manufacturing because they can be incorporated into various formulations and support efficient processing, blending, and dosage preparation. Their broad usability makes them suitable for manufacturers producing different types of pharmaceutical products. Crystals account for a 30% market share and are expected to grow at a 5.8% CAGR, reflecting their continued use in formulations that require crystalline excipient forms.
Diluents are the leading application in the Sugar Based Excipients Market, accounting for a 40% market share and recording a 5.8% CAGR. Diluents play an important role in pharmaceutical manufacturing by adding suitable volume to formulations and supporting the production of dosage forms with consistent characteristics. Their widespread application makes them an important part of excipient demand. Fillers account for a 25% market share and are projected to grow at a 6.5% CAGR, supported by their role in improving the physical properties and manufacturability of pharmaceutical products.
Oral formulations lead the Sugar-Based Excipients Market, accounting for a 55% market share and recording a 5.9% CAGR. Oral formulations remain important because they offer a convenient and widely used method of administering medicines. Sugar-based excipients can support oral products by contributing to formulation functionality and improving characteristics such as taste, texture, and overall product acceptability. Parenteral formulations hold a 25% market share and are projected to register the fastest growth at a 7.3% CAGR. Their growth highlights the increasing importance of excipients designed for formulations that require strict quality and performance requirements.
Speak to an Analystto discuss market opportunities.
Europe is the dominant regional market for sugar-based excipients, accounting for a 34% market share with a market value of $0.48 billion and a 5.8% CAGR. The region benefits from its established pharmaceutical manufacturing base, strong regulatory framework, and continued demand for high-quality pharmaceutical ingredients. Sugar-based excipients are used across different formulations and dosage forms, supporting the production of medicines for a wide range of therapeutic applications.
Germany plays an important role in Europe's sugar-based excipients market due to its strong pharmaceutical and healthcare industries. The country's established manufacturing infrastructure supports demand for high-quality pharmaceutical ingredients used in drug formulation and production. Pharmaceutical manufacturers require excipients that provide consistent performance, quality, and compatibility with different dosage forms. This creates opportunities for suppliers offering reliable sugar-based ingredients and technical support. Demand is also supported by the country's focus on research, development, and advanced pharmaceutical manufacturing.
The United Kingdom represents an important market for sugar-based excipients, supported by its well-developed pharmaceutical and life sciences sector. The country's pharmaceutical manufacturers and research organizations create demand for specialized ingredients used in drug development and production. Sugar-based excipients can contribute to formulation performance and are relevant across various pharmaceutical applications. Demand is influenced by the continued development of medicines, increasing attention to product quality, and the need for reliable pharmaceutical supply chains. Manufacturers also require excipients that meet strict quality and regulatory expectations.
Asia-Pacific is the fastest-growing regional market for sugar-based excipients, with a 28% market share, a market value of $0.39 billion, and the highest 7.4% CAGR among the listed regions. The region's growth is supported by expanding pharmaceutical manufacturing, increasing healthcare demand, and rising production of medicines across developing and established markets. The growing pharmaceutical industries of China and Japan create opportunities for excipient suppliers serving both domestic and international drug manufacturers.
Japan is a significant pharmaceutical market in Asia-Pacific, supported by its advanced healthcare system, mature pharmaceutical industry, and strong focus on product quality. The country's pharmaceutical manufacturers require high-quality excipients that can meet strict formulation and manufacturing requirements. Sugar-based excipients can be used in different pharmaceutical products where consistent functionality and formulation performance are important. Demand is also supported by Japan's aging population and the resulting need for medicines for long-term health conditions.
China is a major pharmaceutical manufacturing hub in Asia-Pacific and plays an important role in regional demand for sugar-based excipients. The country's large pharmaceutical production base supports the need for functional ingredients used in a broad range of drug formulations. Growing healthcare requirements and the expansion of domestic pharmaceutical manufacturing are key factors supporting demand. Local manufacturers are increasingly focused on improving production quality and developing more advanced pharmaceutical products, which can create opportunities for suppliers of consistent and reliable excipients.
North America holds a 22% market share in the sugar-based excipients market, with a market value of $0.31 billion and a 5.9% CAGR. The region benefits from a highly developed pharmaceutical industry, advanced drug manufacturing capabilities, and strong demand for quality pharmaceutical ingredients. The United States is a major contributor to regional pharmaceutical activity, while Canada also supports demand through its healthcare and pharmaceutical sectors. Manufacturers in the region require excipients that meet strict quality standards and provide consistent performance in different formulations.
The United States is a major pharmaceutical market with substantial demand for high-quality excipients used in drug development and manufacturing. Its advanced pharmaceutical industry supports the use of sugar-based ingredients across different formulations and dosage forms. Manufacturers place strong emphasis on consistent quality, regulatory compliance, supply reliability, and technical performance when selecting excipients. Demand is also influenced by continued pharmaceutical innovation and the production of medicines for chronic and complex health conditions. Suppliers that can provide reliable sourcing and meet strict quality expectations can find opportunities in the market.
Canada's sugar-based excipients market is supported by its pharmaceutical and healthcare industries, along with demand for reliable ingredients used in drug manufacturing. Pharmaceutical companies require excipients that meet quality and safety expectations while providing consistent performance during production. Sugar-based excipients can serve different functional roles in pharmaceutical formulations, supporting their use across a range of products. The country's healthcare system and pharmaceutical research activities contribute to ongoing demand for medicines and related manufacturing inputs.
Latin America accounts for a 9% market share in the sugar-based excipients market, with a market value of $0.13 billion and a 6.8% CAGR. The region's pharmaceutical sector creates demand for excipients used in the manufacturing of medicines and other healthcare products. Growth is supported by expanding healthcare requirements, increasing access to medicines, and the development of local pharmaceutical manufacturing capabilities. Brazil is an important market in the region, supported by its large healthcare sector and pharmaceutical industry.
Brazil is an important pharmaceutical market in Latin America, supported by its large healthcare sector and established pharmaceutical manufacturing activities. The country has demand for pharmaceutical ingredients used in the production of different medicines and dosage forms. Sugar-based excipients can support manufacturers seeking functional ingredients for formulation and production processes. Demand is influenced by healthcare needs, pharmaceutical production, and the continued availability of medicines for consumers. Local manufacturers also require consistent supplies of quality ingredients to maintain production efficiency and meet applicable standards.
Africa presents emerging opportunities for sugar-based excipients as pharmaceutical manufacturing and healthcare access continue to develop across the continent. Demand for pharmaceutical ingredients is linked to the need for medicines and the gradual expansion of local healthcare and drug production capabilities. Sugar-based excipients can support manufacturers producing different pharmaceutical formulations where suitable functional ingredients are required. The market also faces the need for dependable supply chains, quality assurance, and access to pharmaceutical-grade raw materials.
The Middle East and Africa region accounts for a 7% market share in the sugar-based excipients market, with a market value of $0.1 billion and a 6.5% CAGR. The region's pharmaceutical sector is supported by increasing healthcare requirements, investments in healthcare infrastructure, and efforts to strengthen medicine supply capabilities. Demand for pharmaceutical-grade excipients is linked to the production of medicines and the development of local pharmaceutical manufacturing. The UAE is an important market within the region, supported by its advanced healthcare infrastructure and growing interest in pharmaceutical and life sciences activities.
The UAE is an important pharmaceutical and healthcare market in the Middle East, supported by modern healthcare infrastructure and growing investment in life sciences. The country's strategic position as a regional business and logistics hub can support the distribution of pharmaceutical ingredients across nearby markets. Pharmaceutical manufacturers and healthcare companies require reliable access to quality ingredients for medicine production and formulation. Sugar-based excipients can serve functional roles in different pharmaceutical products, creating opportunities for suppliers with consistent quality and dependable supply capabilities.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
We are featured on:
sales@straitsresearch.com